UK pharma major GSK today announced positive results from its two pivotal Phase III trials, B-Well 1 [NCT05630807] and B-Well ...

Immune-mediated diseases specialist Alumis has announced positive top-line results from its Phase III ONWARD1 and ONWARD2 ...

Netherlands-based Scenic Biotech, a company advancing modifier therapy—a radical new approach to treating genetic ...

Swiss anti-infectives specialist Basilea has struck a research collaboration with US biotech Prokaryotics to develop a ...

UK biotech AstronauTx has appointed Adam Rosenberg as chairman of its board, succeeding Tim Edwards, as the company advances ...

Industry groups are urging changes to the US Food and Drug Administration’s Biosimilar User Fee Amendments programme as talks ...

Chinese biopharma Hutchmed today announces that the Phase III registration part of the ESLIM-02 clinical trial of sovleplenib ...

Ireland-headquartered Jazz Pharmaceuticals closed Tuesday’s trading 4% lower despite announcing positive efficacy and safety ...

US healthcare major Johnson & Johnson (NYSE: JNJ) has submitted a Type II variation to the European Medicines Agency seeking ...

New York-based clinical-stage biotech LB Pharmaceuticals had announced the appointments of Ellen Rose as senior vice ...

German contract development and manufacturing company ProBioGen has announced the signing of a master service agreement (MSA) ...

US biotech BostonGene has struck a research collaboration with British pharma AstraZeneca (LSE: AZN) to explore the use of ...